{"filing":{"accession_number":"0001104659-26-097242","cik":"0002006986","ticker":"ADGM","company_name":"Adagio Medical Holdings, Inc.","form":"8-K","filing_date":"2026-08-14","report_date":"2026-08-13","primary_document":"tm2623192d2_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2006986/000110465926097242/tm2623192d2_8k.htm"},"events":[{"id":27977,"run_id":25554,"accession_number":"0001104659-26-097242","anchor_item_number":"3.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"summary":"Adagio Medical received a deficiency letter from Nasdaq on August 13, 2026, notifying the company that it failed to maintain the minimum stockholders' equity requirement of $2,500,000 for continued listing on the Nasdaq Capital Market. The company reported negative stockholders' equity of $(415,000) as of June 30, 2026, and does not meet alternative quantitative standards. The company has 45 calendar days to submit a compliance plan or face potential delisting. This is a clear notice of failure to satisfy a continued listing rule under Item 3.01.","company_name":"Adagio Medical Holdings, Inc.","ticker":"ADGM","filing_date":"2026-08-14","form":"8-K","submitted_at":null,"items":[{"id":29718,"accession_number":"0001104659-26-097242","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"Adagio Medical received a deficiency letter from Nasdaq on August 13, 2026, notifying the company that it failed to maintain the minimum stockholders' equity requirement of $2,500,000 for continued listing on the Nasdaq Capital Market. The company reported negative stockholders' equity of $(415,000) as of June 30, 2026, and does not meet alternative quantitative standards. The company has 45 calendar days to submit a compliance plan or face potential delisting. This is a clear notice of failure to satisfy a continued listing rule under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T20:43:21.115819+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":29718,"accession_number":"0001104659-26-097242","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"Adagio Medical received a deficiency letter from Nasdaq on August 13, 2026, notifying the company that it failed to maintain the minimum stockholders' equity requirement of $2,500,000 for continued listing on the Nasdaq Capital Market. The company reported negative stockholders' equity of $(415,000) as of June 30, 2026, and does not meet alternative quantitative standards. The company has 45 calendar days to submit a compliance plan or face potential delisting. This is a clear notice of failure to satisfy a continued listing rule under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T20:43:21.115819+00:00","company_name":"Adagio Medical Holdings, Inc.","ticker":"ADGM","filing_date":"2026-08-14"}]}